Key Metric Identified to Improve Focused Ultrasound Treatment for High-Grade Gliomas
New research identifies a vital acoustic emission dose metric that could improve the safety and effectiveness of focused ultrasound treatments for brain tumors, enabling better drug delivery through the blood-brain barrier.
Recent research has pinpointed a critical measurement that can enhance the precision of focused ultrasound therapy used in treating patients with high-grade gliomas, including aggressive brain tumors like glioblastoma. This breakthrough revolves around the concept of acoustic emission dose—an acoustic signal produced by microbubbles during ultrasound procedures—which can serve as a predictor for optimal blood-brain barrier (BBB) opening.
The blood-brain barrier, a highly selective protective boundary of brain blood vessels, often impedes the delivery of therapeutic drugs to the brain tissue. To overcome this barrier, scientists have developed a technique involving low-power focused ultrasound combined with microbubbles, a method that temporarily disrupts the BBB to facilitate drug delivery.
In a collaborative study between researchers at Mass General Brigham and the University of Maryland School of Medicine, the team analyzed 972 ultrasound applications across 58 treatments in 23 patients. Their findings revealed that maintaining the acoustic emission dose within a target window—specifically between 0.5 and 1.6—allows clinicians to reliably open the BBB while minimizing potential damage. This acoustic emission monitoring provides a new, standardized approach to optimizing treatment safety and effectiveness.
The study builds on foundational work from the 1990s and demonstrates the translation of preclinical discoveries into human applications. Senior author Dr. Alexandra J. Golby notes that this represents a significant advancement in the field, promising improved treatment options for patients with limited alternatives. Continued research will further evaluate the safety and efficacy of repeated ultrasonic BBB openings, opening new possibilities for targeted brain therapies.
According to Dr. Golby, "This research shows the potential to repeatedly open the blood-brain barrier safely, offering hope for enhanced treatment strategies for glioma patients." The key metric—acoustic emission dose—may unify focused ultrasound practices and pave the way for more precise and safe brain treatments.
For more details, visit source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
One-Third of Licensed GPs in England Not Practicing in NHS General Practice
A new study reveals that one-third of licensed GPs in England are not working within NHS primary care, highlighting workforce challenges and increasing patient workloads.
Understanding Sex Differences in Heart Disease to Enhance Personalized Treatments
Emerging research highlights the importance of understanding biological sex differences in heart disease, leading to more personalized and effective treatment options for aortic valve stenosis.
Addressing Stigmatizing Language in Large Language Models and Healthcare Communication
Recent research reveals that large language models can unintentionally use stigmatizing language about individuals with alcohol and substance use disorders. Prompt engineering can significantly reduce this harmful language, enhancing healthcare communication and patient trust.
Revolutionizing Medical Implants with Diamond-Enhanced Energy Harvesting
Innovative diamond–titanium devices developed at RMIT University could enable implants to harvest energy from bodily fluids and wireless signals, eliminating the need for batteries and enhancing durability and safety.